Armata Pharmaceuticals, Inc. — Director's Dealing 2006

Jun 13, 2006

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: TARGETED GENETICS CORP /WA/ (TGEN)
CIK: 0000921114
Period of Report: 2006-06-12

Reporting Person: PARKER H STEWART (Director, President & CEO)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2006-06-12	Employee Stock Option (right to buy)	$3.80	A	38000	Acquired	2016-06-12	Common Stock (38000)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	211755	Direct

Footnotes

F1: This amount represents a premium to the closing price of the common stock on the date of grant.

F2: Such option vests and is exercisable 8.33% monthly, commencing July 12, 2006, with 100% vested and exercisable on June 12, 2007.